Urolithin A promotes atherosclerotic plaque stability by limiting inflammation and hypercholesteremia in Apolipoprotein E–deficient mice

Xu, M., Xu, J., Kang, L., Liu, Z., Su, M., Zhao, W., Wang, Z., Sun, L., Xiao, J., Evans, P.C., Tian, X., Wang, L., Huang, Y., Liang, X., Weng, J., &amp; Xu, S. (2024). Urolithin A promotes atherosclerotic plaque stability by limiting inflammation and hypercholesteremia in Apolipoprotein E–deficient mice. <em>Acta Pharmacologica Sinica</em>. https://doi.org/10.1038/s41401-024-01317-5

Xu M, Xu J, Kang L, Liu Z, Su M, Zhao W, et al. Urolithin A promotes atherosclerotic plaque stability by limiting inflammation and hypercholesteremia in Apolipoprotein E–deficient mice. Acta Pharmacologica Sinica. 2024. doi:10.1038/s41401-024-01317-5.

@unpublished{mengyun2024Urolit, title = {Urolithin A promotes atherosclerotic plaque stability by limiting inflammation and hypercholesteremia in Apolipoprotein E–deficient mice}, author = {Mengyun Xu and Jingjing Xu and Lijing Kang and Zhenghong Liu and Mei-ming Su and Wenqi Zhao and Zhi-hua Wang and Lu Sun and Jianbo Xiao and Paul C. Evans and Xiao-yu Tian and Li Wang and Yu Huang and Xinmiao Liang and Jianping Weng and Suowen Xu}, journal = {Acta Pharmacologica Sinica}, year = {2024}, doi = {10.1038/s41401-024-01317-5}, }